Carlo Torti
Carlo Torti
Email verificata su
TitoloCitata daAnno
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
R Weber, CA Sabin, N Friis-Moller, P Reiss, WM El-Sadr, O Kirk, F Dabis, ...
Arch Intern Med 166 (15), 1632-41, 2006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
F Raffi, A Rachlis, HJ Stellbrink, WD Hardy, C Torti, C Orkin, M Bloch, ...
The Lancet 381 (9868), 735-743, 2013
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ...
The Lancet infectious diseases 11 (5), 363-371, 2011
Natural history of chronic hepatitis B in co-infected patients
M Puoti, C Torti, R Bruno, G Filice, G Carosi
Journal of hepatology 44, S65-S70, 2006
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study …
A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ...
PLoS medicine 10 (9), e1001510, 2013
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
Dolutegravir in antiretroviral-experienced patients with raltegravir-and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study
A Castagna, F Maggiolo, G Penco, D Wright, A Mills, R Grossberg, ...
The Journal of infectious diseases 210 (3), 354-362, 2014
Response to combination antiretroviral therapy: variation by age
Collaboration of Observational HIV Epidemiological Research Europe (COHERE ...
Aids 22 (12), 1463-1473, 2008
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort …
Collaboration of Observational HIV Epidemiological Research Europe (COHERE ...
International journal of epidemiology 41 (2), 433-445, 2011
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis
A Gori, C Tincati, G Rizzardini, C Torti, T Quirino, M Haarman, KB Amor, ...
Journal of clinical microbiology 46 (2), 757-758, 2008
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome
M Puoti, C Torti, D Ripamonti, F Castelli, S Zaltron, B Zanini, A Spinetti, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 32 (3), 259-267, 2003
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
A Gori, G Rizzardini, B Van't Land, KB Amor, J Van Schaik, C Torti, ...
Mucosal immunology 4 (5), 554, 2011
Prevalence and distribution of soil‐transmitted helminth (STH) infections in urban and indigenous schoolchildren in Ortigueira, State of Paranà, Brasil: implications for control
C Scolari, C Torti, A Beltrame, A Matteelli, F Castelli, M Gulletta, M Ribas, ...
Tropical Medicine & International Health 5 (4), 302-307, 2000
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE
Opportunistic Infections Project Team of the Collaboration of Observational ...
PLoS medicine 9 (3), e1001194, 2012
Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery
FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ...
Clinical infectious diseases 58 (9), 1312-1321, 2014
Risk of triple-class virological failure in children with HIV: a retrospective cohort study
Pursuing Later Treatment Options II (PLATO II) project team for the ...
The Lancet 377 (9777), 1580-1587, 2011
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART
B Ensoli, S Bellino, A Tripiciano, O Longo, V Francavilla, S Marcotullio, ...
PloS one 5 (11), e13540, 2010
The development of artificial neural networks to predict virological response to combination HIV therapy
B Larder, D Wang, A Revell, J Montaner, R Harrigan, F De Wolf, J Lange, ...
Antiviral therapy 12 (1), 15, 2007
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20